1. Home
  2. OPK vs CRAI Comparison

OPK vs CRAI Comparison

Compare OPK & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • CRAI
  • Stock Information
  • Founded
  • OPK 2007
  • CRAI 1965
  • Country
  • OPK United States
  • CRAI United States
  • Employees
  • OPK N/A
  • CRAI N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • CRAI Other Consumer Services
  • Sector
  • OPK Health Care
  • CRAI Consumer Discretionary
  • Exchange
  • OPK Nasdaq
  • CRAI Nasdaq
  • Market Cap
  • OPK 1.1B
  • CRAI 1.4B
  • IPO Year
  • OPK 1995
  • CRAI 1998
  • Fundamental
  • Price
  • OPK $1.31
  • CRAI $176.27
  • Analyst Decision
  • OPK Buy
  • CRAI Buy
  • Analyst Count
  • OPK 5
  • CRAI 1
  • Target Price
  • OPK $2.28
  • CRAI $239.00
  • AVG Volume (30 Days)
  • OPK 2.7M
  • CRAI 85.7K
  • Earning Date
  • OPK 10-29-2025
  • CRAI 10-30-2025
  • Dividend Yield
  • OPK N/A
  • CRAI 1.10%
  • EPS Growth
  • OPK N/A
  • CRAI 34.79
  • EPS
  • OPK N/A
  • CRAI 8.34
  • Revenue
  • OPK $642,067,000.00
  • CRAI $731,055,000.00
  • Revenue This Year
  • OPK N/A
  • CRAI $10.26
  • Revenue Next Year
  • OPK N/A
  • CRAI $3.48
  • P/E Ratio
  • OPK N/A
  • CRAI $21.31
  • Revenue Growth
  • OPK N/A
  • CRAI 8.69
  • 52 Week Low
  • OPK $1.11
  • CRAI $152.57
  • 52 Week High
  • OPK $2.04
  • CRAI $214.66
  • Technical
  • Relative Strength Index (RSI)
  • OPK 41.15
  • CRAI 42.96
  • Support Level
  • OPK $1.24
  • CRAI $169.81
  • Resistance Level
  • OPK $1.35
  • CRAI $180.61
  • Average True Range (ATR)
  • OPK 0.06
  • CRAI 5.97
  • MACD
  • OPK 0.00
  • CRAI -0.34
  • Stochastic Oscillator
  • OPK 51.35
  • CRAI 27.91

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

Share on Social Networks: